| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/19/2023 | Assertio Holdings, Inc. | ASRT | Sale | Common Stock | 89.3k | $7.30 | $652k | | 05/19/2023 |
| 05/10/2023 | Assertio Holdings, Inc. | ASRT | Grant | Common Stock | 31.2k | $0.00 | $0 | | 05/10/2023 |
| 05/10/2023 | Assertio Holdings, Inc. | ASRT | Grant | Stock Option (right to buy) | 3.8k | $7.55 | $28.8k | | 05/10/2023 |
| 05/04/2022 | Assertio Holdings, Inc. | ASRT | Grant | Common Stock | 86.3k | $0.00 | $0 | | 05/04/2022 |
| 02/18/2022 | Assertio Holdings, Inc. | ASRT | Exercise | Restricted Stock Units | 3.6k | $0.00 | $0 | | 02/18/2022 |
| 05/11/2021 | Assertio Holdings, Inc. | ASRT | Grant | Common Stock | 357.1k | $0.00 | $0 | | 05/11/2021 |
| 02/18/2021 | Assertio Holdings, Inc. | ASRT | Exercise | Restricted Stock Units | 14.4k | $0.00 | $0 | | 02/18/2021 |
| 05/19/2020 | Assertio Holdings, Inc. | ASRT | Grant | Common Stock | 237.5k | $0.00 | $0 | | 05/19/2020 |
| 02/18/2020 | Assertio Therapeutics, Inc | ASRT | Exercise | Restricted Stock Units | 14.4k | $0.00 | $0 | | 02/18/2020 |
| 02/18/2019 | Assertio Therapeutics, Inc | ASRT | Grant | | 43.2k | $0.00 | $0 | | 02/18/2019 |
| 02/28/2017 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 8.5k | $45.46 | $387.8k | | 02/28/2017 |
| 02/28/2017 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 1.7k | $45.02 | $75.5k | | 02/28/2017 |
| 02/28/2017 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 134 | $45.01 | $6k | | 02/28/2017 |
| 02/28/2017 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 100 | $45.01 | $4.5k | | 02/28/2017 |
| 01/31/2017 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 35.7k | $40.77 | $1.5M | | 01/31/2017 |
| 01/31/2017 | ABBOTT LABORATORIES | ABT | Exercise | | 35.7k | $25.25 | $901.3k | | 01/31/2017 |
| 07/01/2016 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 613 | $39.31 | $24.1k | | 07/01/2016 |
| 02/28/2011 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 7k | $47.64 | $335.5k | | 02/28/2011 |
| 02/28/2011 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 1.8k | $47.94 | $88.4k | | 02/28/2011 |
| 02/18/2011 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 22.2k | $0.00 | $0 | | 02/18/2011 |
| 02/18/2011 | ABBOTT LABORATORIES | ABT | Grant | | 31.2k | $46.60 | $1.5M | | 02/18/2011 |
| 06/29/2010 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 2.3k | $47.18 | $110.1k | | 06/29/2010 |
| 02/26/2010 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 6.6k | $54.12 | $359.3k | | 02/26/2010 |
| 02/26/2010 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 294 | $54.25 | $16k | | 02/26/2010 |
| 11/11/2009 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 2.2k | $53.50 | $115.1k | | 11/11/2009 |
| 11/11/2009 | ABBOTT LABORATORIES | ABT | Exercise | | 1.3k | $51.91 | $66.1k | | 11/11/2009 |
| 11/11/2009 | ABBOTT LABORATORIES | ABT | Exercise | | 878 | $53.24 | $46.7k | | 11/11/2009 |